Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

Publication | Open Access

DOI Full Paper Access

Citations

References

2013

Year

Hans Gelderblom, Jean‐Yves Blay, Beatrice Seddon, Michael Leahy, Isabelle Ray‐Coquard, Stefan Sleijfer, J. Martijn Kerst, Piotr Rutkowski, Sebastian Bauer, M. Ouali,

European Journal of Cancer

Brostallicin Versus DoxorubicinPhase IiMedicinePharmacologyPathologyAnti-cancer AgentCancer TreatmentCancer Soft TissueOncologyRadiation OncologyChemotherapyCancer Research